February 17, 2026

Janux Therapeutics, Inc. (JANX) Investor Outlook: A Potential 383.93% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology industry, has captured investor attention with its cutting-edge immunotherapy platforms and a notably high potential upside of 383.93%. As..

Harrow, Inc. (HROW) Stock Analysis: A 48% Potential Upside in the Eye-Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a prominent player in the healthcare sector, specializes in the development of ophthalmic pharmaceutical products. Headquartered in Nashville, Tennessee, this company has carved out a niche..

SS Innovations International (SSII) Stock Analysis: Exploring a Potential Growth Story in Surgical Robotics

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector specializing in medical devices, is making waves in the surgical robotics industry. With a market capitalization of $837.68..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 53.4% Revenue Growth and a 7.73% Upside Potential

Kestra Medical Technologies, Ltd. (KMTS), a notable player in the healthcare sector, is making waves in the medical instruments and supplies industry. Focused on enhancing cardiovascular patient outcomes through innovative..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Burlington, Massachusetts, LeMaitre Vascular..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: 13.48% Potential Upside Attracts Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG) is drawing attention from investors with its intriguing potential upside of 13.48%, as analysts set an average target price of $24.50. Operating within the..

Progyny, Inc. (PGNY) Stock Analysis: Discovering a 49.39% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) has been making waves in the healthcare sector, particularly within the niche of fertility and women’s health benefits solutions. With a market capitalization of $1.78 billion,..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A 50.75% Upside Potential in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has garnered attention in the biotech sector, particularly for individual investors seeking high-growth opportunities. With a market capitalization of $2.66 billion, Viridian stands out as..

Acadia Healthcare (ACHC) Stock Analysis: Exploring the 13.72% Potential Upside

Acadia Healthcare Company, Inc. (ACHC), a key player in the healthcare sector, specializes in providing essential behavioral healthcare services across the United States and Puerto Rico. With its expansive reach,..

Dynavax Technologies (DVAX) Stock Analysis: Exploring the 3.23% Upside Potential in the Burgeoning Vaccine Market

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the biopharmaceutical sector, is making waves with its focus on developing and commercializing innovative vaccines. With a market capitalization of $1.82..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 188% Potential Upside with Strong Buy Ratings

For investors with an eye on biotech, Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity. Specializing in innovative therapies for retinal diseases and other eye conditions, this Massachusetts-based company..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Strong Revenue Growth and Potential Upside in Medical Devices

Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to aesthetic and reconstructive plastic surgery,..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Play with 57.77% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is attracting considerable attention in the investment community, particularly among those with an eye for high-reward opportunities in the biotechnology sector. With a market capitalization of..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem with 7.78% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, stands at a pivotal point in its growth trajectory. Specializing in the development of innovative antibody therapeutics, Merus is making waves in..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 69.81% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a key player in the biotechnology sector, is garnering significant attention from investors, thanks to its promising pipeline and substantial growth potential. With a current market..

Perrigo Company plc (PRGO): Valuation Insights Reveal Significant 44% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, stands out in the drug manufacturing industry with its focus on over-the-counter health and wellness solutions. Headquartered in..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Consensus Predicts 84.84% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention in the healthcare sector for its innovative focus on hematologic diseases. Headquartered in Watertown, Massachusetts, Disc Medicine is..

NeoGenomics, Inc. (NEO) Investor Outlook: Assessing the 27.97% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) stands as a noteworthy contender within the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of $1.47 billion and operating..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 42.84% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) emerges as a compelling opportunity within the healthcare sector, particularly in the high-demand sphere of specialty and generic drug manufacturing. With a market capitalization of..

Pediatrix Medical Group (MD) Stock Analysis: Exploring Growth Potential and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the medical care facilities industry, holds a distinctive position within the healthcare sector. With a market capitalization of $1.87 billion,..

Search

Funds

February 17, 2026

Search

Funds

February 17, 2026

FTSE 100

Funds